Skip to main content
. 2020 Apr 22;111(6):1910–1920. doi: 10.1111/cas.14401

FIGURE 1.

FIGURE 1

Pemetrexed (PEM) decreases the viability of non–small‐cell lung cancer (NSCLC) cells. Cancer cells were cultured in the presence of the indicated doses of PEM for 2 d. The percent cell viability was determined by WST8 assay. **P < 0.01